Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Photys Therapeutics’ proprietary bifunctional small molecules platform unlocks fine-tuned control of protein modifications.
Thankful is a Developer of an automation software created to improve online customer service.
Anjarium is focused on creating new class of non-viral gene therapies to deliver predictable ,inclusionary ways to tackle genetic diseases.
GelSight provides extremely detailed and rapid surface measurements through the novel GelSight sensor technology.
NeuroVision Imaging is a developer of digital imaging and diagnostic solutions for Alzheimer's disease.
etherna develops mRNA and lipid nanoparticle solutions.
XII Medical provides minimally invasive technology for obstructive sleep apnea.
CatalYm is a biotechnology company developing innovative immunotherapies for cancer patients.
Ousia Pharma focuses on the design and development of pharmacotherapies to improve the health and lives of people living with obesity.
Editas Medicine is a clinical-stage genome editing company that develops genomic medicines for serious diseases.
Sana Biotechnology is a developer of engineered cells intended to be used as medicine for patients.
Antares is a biotechnology company focused on developing transformational,medicines targeting validated cancer and other serious diseases.
Endeavor BioMedicines develops new treatments targeting the underlying causes of pulmonary fibrosis.
Spruce Biosciences is a biopharmaceutical company developing therapies for rare diseases that target the endocrine system.
Trevi Therapeutics is a clinical-stage biopharmaceutical company that develops drugs for treating uremic pruritus.
CDR-Life AG is a biotech company that develops innovative therapeutic antibody fragments with a focus on immuno-oncology.
NRG Therapeutics is a drug discovery company focussed on therapeutic approaches that will restore mitochondrial function.
ARTBIO is a clinical-stage radiopharmaceutical biotechnology business that is working to create a new class of alpha radioligand medicines.
HydroCision develops, manufactures, and markets fluid jet-based surgical tools for minimally invasive spine surgery requirements.
Callio Therapeutics develops next-generation, multi-payload antibody-drug conjugates (ADCs).
Vanqua Bio is a biotechnology company that discovers and develops next-generation medicines for patients with neurodegenerative diseases.
BBOT is a clinical-stage biopharmaceutical company advancing a pipeline of novel therapeutics targeting RAS and PI3K malignancies.
Eyebiotech is an ophthalmology biotechnology company that specializes in therapies for eye diseases.
Spiro Medical is a medical device company developing a groundbreaking Pulmonary Neuromodulation (PNM) System for asthma treatment.
Omega Funds has invested in 79 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Omega Funds's top investment sectors include Biotechnology, Health Care, Medical, Pharmaceutical, Therapeutics. The firm invests across 28 different industry categories.
Among tracked funding rounds, BBOT received $200.0M in a Venture - Series Unknown round. Omega Funds's total known invested capital is $5.7B.
Omega Funds's average investment size is $96.1M across its portfolio of 79 companies.
Recent Omega Funds portfolio additions include Photys Therapeutics, Thankful, Anjarium Biosciences, GelSight, NeuroVision Imaging. These companies were founded in 2020 or later.